Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empiric vs Selective Prevention Strategies for Kidney Stone Disease
NCT05365477Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indapamide, potassium citrate, allopurinol, potassium chloride in nephrolithiasis, sponsored by Vanderbilt University Medical Center. Started Aug 2022; status: completed.
02
Drugs
indapamidepotassium citrateallopurinolpotassium chloride
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT05365477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05365477.